Related Experiment Video
Updated: Aug 8, 2026
07:17
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
Published on: April 14, 2016
Optimizing patient therapy: the role of bone markers?
1Université de Montréal, CHUM/Hôpital Notre-Dame, 1560 Sherbrook E, Montreal, Québec H2L 4M1, Canada. fredsaad@videotron.ca
Cancer Treatment Reviews
|May 9, 2006
Summary
Reduced bone turnover, measured by bone markers, correlates with better outcomes in metastatic bone disease. Bone markers can identify high-risk patients and guide treatment, potentially improving quality of life.
Area of Science:
- Oncology
- Bone Metabolism
- Biomarkers
Background:
- Metastatic bone disease (MBD) leads to skeletal-related events (SREs), impacting patient quality of life (QOL).
- Abnormal bone turnover is a key feature of MBD.
- Current management strategies for MBD and SREs require optimization.
Purpose of the Study:
- To review the role of bone turnover markers in managing MBD.
- To explore the relationship between SREs and bone turnover.
- To assess the potential of bone markers in guiding treatment and improving patient QOL.
Main Methods:
- Literature review focusing on bone turnover markers, SREs, and MBD.
- Analysis of studies correlating bone marker levels with patient outcomes.
- Examination of the utility of bone markers in treatment monitoring.
Main Results:
- Reduced bone turnover activity, indicated by bone markers, correlates with improved patient outcomes.
- Bone markers can help identify patients at higher risk for SREs.
- Bone markers show promise in monitoring treatment response and personalizing therapy.
Conclusions:
- Bone markers are valuable tools for managing MBD and identifying patients at risk for SREs.
- Further research is needed, but bone markers are expected to play a significant role in optimizing MBD treatment.
- Utilizing bone markers may lead to improved patient QOL by guiding more effective and personalized treatment strategies.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...